Background Hemodynamic alterations of extracranial veins are considered an etiologic
factor in multiple sclerosis (MS). However, ultrasound and MRI studies could not confirm a …

Background Venous percutaneous transluminal angioplasty (vPTA) in patients with multiple
sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI) have shown …

Background: We conducted a rigorous review of videos related to multiple sclerosis (MS)
and chronic cerebrospinal venous insufficiency (CCSVI) treatment posted by people with MS …

In 1889, Charcot described the results of “suspension therapy” for tabes dorsalis and other
diseases. 1 The procedure entailed suspending patients from a harness attached to their …

Objective: The objective of this longitudinal study examined, first, whether people with
multiple sclerosis who previously advocated for angioplasty to treat chronic cerebral spinal …

Although the aetiology of Multiple Sclerosis (MS) is unknown, genetic and environmental
factors including infectious agents may play a role in the development of this disease …

Background Multiple sclerosis (MS) is a chronic demyelinating disease of the central
nervous system that affects mainly young adults, but can occur also in children and …

Abstract Objective Verify whether Percutaneous Transluminal Angioplasty (PTA) may affect
neural conduction properties in Multiple Sclerosis (MS) patients, thereby modifying patients' …

Hence, MS is one of the most frequent chronic neurologic diseases and the leading cause of
disability in young and middle-aged individuals in the developed world. 1 Strategies to …

Multiple sclerosis (MS) is an inflammatory disease, which is immune-mediated, and
responds to immune-modulating therapies. However, it is uncertain what antigen, or …